Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
2
33%
Ph phase_3
3
50%
Ph phase_1
1
17%

Phase Distribution

1

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 3Large-scale testing
3(50.0%)
Phase 4Post-market surveillance
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(2)
Other(3)

Detailed Status

unknown3
Completed2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 33 (50.0%)
Phase 42 (33.3%)

Trials by Status

not_yet_recruiting117%
unknown350%
completed233%

Recent Activity

0 active trials
Showing 5 of 6
not_yet_recruitingphase_4

Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer

NCT07533266
completedphase_1

A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121

NCT06025773
completedphase_3

Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer

NCT04784910
unknownphase_3

Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDs

NCT04840550
unknownphase_4

The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole)

NCT05820048
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07533266Phase 4

Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer

Not Yet Recruiting
NCT06025773Phase 1

A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121

Completed
NCT04784910Phase 3

Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer

Completed
NCT04840550Phase 3

Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDs

Unknown
NCT05820048Phase 4

The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole)

Unknown
NCT04341428Phase 3

Study to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive Esophagitis

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6